PharmaCyte Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.About PMCB
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
PMCB Key Statistics
Stock Snapshot
The current PharmaCyte Biotech(PMCB) stock price is $0.78, with a market capitalization of 8.59M. The stock trades at a price-to-earnings (P/E) ratio of -0.75.
On 2026-03-24, PharmaCyte Biotech(PMCB) stock moved within a range of $0.70 to $0.82. With shares now at $0.78, the stock is trading +11.8% above its intraday low and -4.6% below the session's peak.
Trading volume for PharmaCyte Biotech(PMCB) stock has reached 567.99K, versus its average volume of 182.08K.
The stock's 52-week range extends from a low of $0.63 to a high of $1.58.
The stock's 52-week range extends from a low of $0.63 to a high of $1.58.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.